Role of Macronutrients in the Regulation and Secretory Mechanisms of Gastrointestinal Hormones, Glucagon-like Peptide-1 (GLP-1) and Glucose-dependent Insulinotropic Polypeptide (GIP), in Lymph

Role of Macronutrients in the Regulation and Secretory Mechanisms of Gastrointestinal Hormones, Glucagon-like Peptide-1 (GLP-1) and Glucose-dependent Insulinotropic Polypeptide (GIP), in Lymph

Bibliographic Details
Main Author:	Lu, Wendell J.
Language:	English
Published:	University of Cincinnati / OhioLINK 2008
Subjects:	Biomedical Research Incretins GLP-1 GIP Lymph Macronutrients Secretory mechanisms
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=ucin1204084153

Similar Items

Effects of Acute Nutrient Stimulation and Chronic High-Fat Feeding on GIP and GLP-1 Secretion in the Lymph Fistula Rat
by: Yoder, Stephanie M.
Published: (2010)

GLP1 and GIP are involved in the action of synbiotics in broiler chickens
by: Pawel Antoni Kolodziejski, et al.
Published: (2018-01-01)

A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor
by: Noura Al-Zamel, et al.
Published: (2019-07-01)

Dual GIP–GLP1-Receptor Agonists In The Treatment Of Type 2 Diabetes: A Short Review On Emerging Data And Therapeutic Potential
by: Bastin M, et al.
Published: (2019-09-01)

The insulinotropic and incretin response to feeding a milk based protein matrix in healthy young women
by: Miryam Amigo-Benavent, et al.
Published: (2020-09-01)

The Origin and Understanding of the Incretin Concept
by: Jens F. Rehfeld
Published: (2018-07-01)

PANCREATIC AND EXTRA-PANCREATIC EFFECTS OF INCRETINS AND PERSPECTIVES FOR STUDYING ENTEROINSULIN HORMONAL SYSTEM DURING GESTATIONAL DISORDER OF CARBOHYDRATE METABOLISM
by: T. V. Saprina, et al.
Published: (2013-06-01)

Incretin Hormones and Type 2 Diabetes—Mechanistic Insights and Therapeutic Approaches
by: Geke Aline Boer, et al.
Published: (2020-12-01)

Incretin hormones as immunomodulators of atherosclerosis
by: Nuria eAlonso, et al.
Published: (2012-09-01)

Glucose-dependent insulinotropic polypeptide (GIP) and GIP receptor (GIPR) genes: An association analysis of polymorphisms and bone in young and elderly women
by: Gaurav Garg, et al.
Published: (2016-06-01)

The effects of nutrition intake on intestinal mucosal repair and metabolic regulation through gut hormones
by: Joo, Erina
Published: (2014)

Absence of GIP secretion alleviates age-related obesity and insulin resistance
by: Kanemaru, Yoshinori
Published: (2020)

The Insulin Response to Oral Glucose in GIP and GLP-1 Receptor Knockout Mice: Review of the Literature and Stepwise Glucose Dose Response Studies in Female Mice
by: Bo Ahrén, et al.
Published: (2021-05-01)

Increased Body Weight and Fat Mass After Subchronic GIP Receptor Antagonist, but Not GLP-2 Receptor Antagonist, Administration in Rats
by: Sara Baldassano, et al.
Published: (2019-08-01)

Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective
by: Joanna Michałowska, et al.
Published: (2021-01-01)

Effects of Enteroendocrine Hormones on Beta-cell Function and Glucose Homeostasis
by: Maida, Adriano
Published: (2011)

Effects of Enteroendocrine Hormones on Beta-cell Function and Glucose Homeostasis
by: Maida, Adriano
Published: (2011)

Glucagon-like peptide-1 analogues: An overview
by: Vishal Gupta
Published: (2013-01-01)

Glucagon-like peptide-1 (GLP-1) and liraglutide, a synthetic GLP-1 analog, inhibit inflammation in human aortic endothelial cells via calcium and AMPK dependent mechanisms
by: Krasner, Nadia Marie
Published: (2016)

Genistein enhances the secretion of glucagon-like peptide-1 (GLP-1) via downregulation of inflammatory responses
by: Kanwal Rehman, et al.
Published: (2019-04-01)

Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide dual receptor agonist DA-CH5 is superior to exendin-4 in protecting neurons in the 6-hydroxydopamine rat Parkinson model
by: Ling-Yu Zhang, et al.
Published: (2021-01-01)

Chronic reduction of GIP secretion alleviates obesity and insulin resistance under high fat diet condition
by: Nasteska, Daniela
Published: (2014)

GI inflammation Increases Sodium-Glucose Cotransporter Sglt1
by: Jiyoung Park, et al.
Published: (2019-05-01)

GLP-1 REGULATES PROLIFERATION OF GLP-1 SECRETING CELLS THROUGH A FEEDBACK MECHANISM
by: Abdullahi Mohamed, Mohamed
Published: (2010)

The novel GLP‐1/GIP analogue DA5‐CH reduces tau phosphorylation and normalizes theta rhythm in the icv. STZ rat model of AD
by: Cheng Li, et al.
Published: (2020-03-01)

First GLP-1 analog liraglutide: the result of clinical trails on efficacy
by: Alexander Sergeevich Ametov, et al.
Published: (2011-12-01)

Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in ob/ob mice
by: Kuwahara, Satoko
Published: (2017)

Free Fatty Acid Receptor GPR120 is Highly Expressed in Enteroendocrine K Cells of the Upper Small Intestine and Has a Critical Role in GIP Secretion After Fat Ingestion
by: Iwasaki, Kanako
Published: (2016)

Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes
by: Fujishima Yuya, et al.
Published: (2012-09-01)

The insulinogenic effect of whey protein is partially mediated by a direct effect of amino acids and GIP on β-cells
by: Salehi Albert, et al.
Published: (2012-05-01)

The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion—A Review
by: David S. Mathiesen, et al.
Published: (2019-08-01)

Glucose-Dependent Insulinotropic Polypeptide Suppresses Foam Cell Formation of Macrophages through Inhibition of the Cyclin-Dependent Kinase 5-CD36 Pathway
by: Michishige Terasaki, et al.
Published: (2021-07-01)

Equine glucagon-like peptide-1 receptor physiology
by: Murad H. Kheder, et al.
Published: (2018-01-01)

Hepatic and Extrahepatic Insulin Clearance in Mice with Double Deletion of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Receptors
by: Micaela Morettini, et al.
Published: (2021-08-01)

Relevance of Autophagy Induction by Gastrointestinal Hormones: Focus on the Incretin-Based Drug Target and Glucagon
by: Keizo Kanasaki, et al.
Published: (2019-05-01)

Investigation of metabolism of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) by dipeptidyl peptidase IV (DP IV)
by: Pauly, Robert P.
Published: (2009)

Investigation of metabolism of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) by dipeptidyl peptidase IV (DP IV)
by: Pauly, Robert P.
Published: (2009)

Obesity without diabetes: the role of hormonal regulation
by: E. A. Shestakova, et al.
Published: (2020-11-01)

Incretin-Based Therapies for Diabetic Complications: Basic Mechanisms and Clinical Evidence
by: Daiji Kawanami, et al.
Published: (2016-07-01)

The role of human glucagon-like peptide-1 analog in therapy of type 2 dianetes mellitus
by: Marina Vladimirovna Shestakova
Published: (2010-09-01)